Business Description
Bioceltix SA
ISIN : PLBCLTX00019
Total Employee Number:
58Description
Bioceltix SA develops therapies for veterinary use that harness the immunomodulatory properties of mesenchymal stem cells. Its pipeline products include BCX-CM-J for Degenerative joint lesions; BCX-CM-S for Autoimmune and inflammatory diseases in dogs; BCX-EM for Tendon damage and BCX-FM for Gingivostomatitis.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 258.69 | |||||
Equity-to-Asset | 0.96 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -4.1 | |||||
3-Year EPS without NRI Growth Rate | -3.9 | |||||
3-Year FCF Growth Rate | -4.1 | |||||
3-Year Book Growth Rate | 106.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 74.18 | |||||
9-Day RSI | 63.68 | |||||
14-Day RSI | 58.96 | |||||
3-1 Month Momentum % | 10.27 | |||||
6-1 Month Momentum % | 10.27 | |||||
12-1 Month Momentum % | -10.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 22.56 | |||||
Quick Ratio | 22.56 | |||||
Cash Ratio | 21.07 | |||||
Days Inventory | 1.94 | |||||
Days Payable | 216.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.3 | |||||
Shareholder Yield % | 0.06 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -36.74 | |||||
ROA % | -34.29 | |||||
ROIC % | -318.37 | |||||
3-Year ROIIC % | -362.68 | |||||
ROC (Joel Greenblatt) % | -432.65 | |||||
ROCE % | -36.43 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 6.82 | |||||
PB Ratio | 7.48 | |||||
Price-to-Tangible-Book | 7.64 | |||||
EV-to-EBIT | -26.21 | |||||
EV-to-EBITDA | -27.26 | |||||
EV-to-FCF | -21.33 | |||||
| Price-to-Net-Current-Asset-Value | 8.34 | |||||
| Price-to-Net-Cash | 8.96 | |||||
Earnings Yield (Greenblatt) % | -3.82 | |||||
FCF Yield % | -4.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bioceltix SA Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.76 | ||
| Beta | 0.8874 | ||
| 3-Year Sharpe Ratio | 0.29 | ||
| 3-Year Sortino Ratio | 0.51 | ||
| Volatility % | 58.59 | ||
| 14-Day RSI | 58.96 | ||
| 14-Day ATR (€) | 1.279587 | ||
| 20-Day SMA (€) | 17.606 | ||
| 12-1 Month Momentum % | -10.25 | ||
| 52-Week Range (€) | 13.98 - 28.6 | ||
| Shares Outstanding (Mil) | 5.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bioceltix SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bioceltix SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bioceltix SA Frequently Asked Questions
What is Bioceltix SA(FRA:XI3)'s stock price today?
The current price of FRA:XI3 is €18.10. The 52 week high of FRA:XI3 is €28.60 and 52 week low is €13.98.
When is next earnings date of Bioceltix SA(FRA:XI3)?
The next earnings date of Bioceltix SA(FRA:XI3) is .
Does Bioceltix SA(FRA:XI3) pay dividends? If so, how much?
Bioceltix SA(FRA:XI3) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Bioceltix SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers